News //

Multifunctional Nanomedicine Developed Using Novel UChicago Tech Gets FDA Nod to Initiate Clinical Trials

Coordination Pharmaceuticals, Inc. (CPI) recently announced that the FDA has approved the company's Investigational New Drug (IND) application to initiate a first-in-human Phase 1 clinical study of its novel cancer…
News //

F3 Platform Biologics Developing Cancer-Preventing Drugs Based on the Work of UChicago Researcher

Amifostine has a long history and today could potentially help prevent the development of approximately 40,000 cancer cases each year - the goal of F3 Platform Biologics. Amifostine has traditionally…
News //

Patent of the Week: Precisely Delivering High Dose Radiation to Multiple Tumor Sites

University of Chicago researchers have developed an algorithm and prototype software package that successfully generates radiation beam angles for more precisely delivering treatment to multiple tumor sites. Stereotactic ablative…
News //

Duckworth Family’s Partnership Drives Cancer Discoveries to Market

A $1 million gift will establish the Duckworth Family Cancer Fund at the University of Chicago Medicine to accelerate the pace of cancer discoveries brought to market.
News //

How Gut Microbes are Joining the Fight Against Cancer

The intestinal microbiome seems to influence how well some cancer drugs work. But is the science ripe for clinical trials? Read the full article here >>
News //

City Club of Chicago: John Flavin, Polsky Center for Entrepreneurship and Innovation

John Flavin leads the Polsky Center for Entrepreneurship and Innovation, which drives the creation of new businesses at the University of Chicago and on Chicago’s South Side. In this role,…
News //

Chicago Booth Entrepreneurs Launch Startup to Halt Cervical Cancer

A team at Chicago’s Booth School of Business has won a competition for female MBA entrepreneurs with a startup idea seeking to reduce the occurrence of cervical cancer through early…
News //

25 Chicago Startups That Are Fighting Cancer

There are more than 100 types of cancer, and about 40% of men and women will be diagnosed with cancer at some point in their lifetime, according to the National…
News //

Will Harnessing Big Data Finally Lead to a Cure for Cancer?

Could big data lead to the next breakthrough in cancer treatment? A major project from the University of Chicago is betting on it. Read more.
News //

Eric Lefkofsky’s Tempus Will Use Data to Help UChicago Battle Breast Cancer

Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the University of Chicago data to help better treat breast cancer patients. Read more.
News //

AbbVie, U of C Choose First Batch of Cancer Research Projects

Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept